全文获取类型
收费全文 | 359651篇 |
免费 | 34267篇 |
国内免费 | 26235篇 |
专业分类
耳鼻咽喉 | 2953篇 |
儿科学 | 3850篇 |
妇产科学 | 4090篇 |
基础医学 | 42113篇 |
口腔科学 | 6150篇 |
临床医学 | 49974篇 |
内科学 | 48882篇 |
皮肤病学 | 3567篇 |
神经病学 | 18997篇 |
特种医学 | 13267篇 |
外国民族医学 | 226篇 |
外科学 | 34052篇 |
综合类 | 65727篇 |
现状与发展 | 103篇 |
一般理论 | 36篇 |
预防医学 | 24305篇 |
眼科学 | 10221篇 |
药学 | 39126篇 |
395篇 | |
中国医学 | 22953篇 |
肿瘤学 | 29166篇 |
出版年
2024年 | 743篇 |
2023年 | 5052篇 |
2022年 | 8696篇 |
2021年 | 18045篇 |
2020年 | 14104篇 |
2019年 | 11852篇 |
2018年 | 12481篇 |
2017年 | 11544篇 |
2016年 | 10753篇 |
2015年 | 16547篇 |
2014年 | 20494篇 |
2013年 | 18711篇 |
2012年 | 27561篇 |
2011年 | 30858篇 |
2010年 | 20248篇 |
2009年 | 16172篇 |
2008年 | 20189篇 |
2007年 | 19901篇 |
2006年 | 19781篇 |
2005年 | 19121篇 |
2004年 | 12072篇 |
2003年 | 11213篇 |
2002年 | 9345篇 |
2001年 | 7844篇 |
2000年 | 8287篇 |
1999年 | 8539篇 |
1998年 | 5510篇 |
1997年 | 5478篇 |
1996年 | 4268篇 |
1995年 | 4075篇 |
1994年 | 3429篇 |
1993年 | 2246篇 |
1992年 | 2601篇 |
1991年 | 2229篇 |
1990年 | 1907篇 |
1989年 | 1631篇 |
1988年 | 1390篇 |
1987年 | 1211篇 |
1986年 | 953篇 |
1985年 | 807篇 |
1984年 | 502篇 |
1983年 | 333篇 |
1982年 | 206篇 |
1981年 | 220篇 |
1980年 | 165篇 |
1979年 | 174篇 |
1978年 | 73篇 |
1975年 | 55篇 |
1974年 | 59篇 |
1973年 | 67篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
目的对不同季铵化程度(DQ)的N-三甲基壳聚糖(TMC)促进阿昔洛韦(ACV)滴眼液眼部滞留性进行考察。方法将浓度为0.5%,DQ分别为20%、40%及60%的TMC(TMC20,TMC40,TMC60)加入ACV滴眼液中;以同浓度壳聚糖(CS)ACV滴眼液为阳性对照,以普通ACV滴眼液为阴性对照,选用家兔为实验动物,采用悬挂泡技术和束缚泡技术进行离体眼球表面接触角及解吸附动力学进行研究,同时在各种ACV滴眼液中分别加入0.05%的荧光素钠为示踪剂,在体研究各种ACV滴眼液在家兔眼部的滞留性。结果与普通ACV滴眼液相比,含CS及TMC的滴眼液在角膜表面的接触角明显降低,解吸时间及在体滞留时间明显延长(P<0.05);与同浓度的CS ACV阳性对照相比,TMC20促进滞留作用较弱,而TMC40作用差异无显著性(P>0.05),而TMC60的作用明显较强(P<0.05)结论 TMC可显著增加ACV的眼部滞留性,且与其DQ呈正相关。 相似文献
83.
Sophocarpine attenuates toll‐like receptor 4 in steatotic hepatocytes to suppress pro‐inflammatory cytokines synthesis 下载免费PDF全文
84.
85.
European Archives of Oto-Rhino-Laryngology - Several polymorphisms in a disintegrin and metalloproteinase 33 (ADAM33) have been implicated in susceptibility to allergic rhinitis (AR), but the... 相似文献
86.
88.
目的:采用网状Meta分析方法,将普萘洛尔联合其他治疗与各对照治疗措施进行对比。方法:以“普萘洛尔”,“血管瘤”为关键词检索CNKI、VIP、万方数据;以“propranolol”“hemangioma”为关键词检索Cochrane Library、Embase、pubmed。检索期限为建库至2019年6月1日。采用STATA14.0软件Network程序包进行数据分析。结果:共纳入18篇文献,涉及8项治疗措施,共纳入1469例血管瘤患者。网状Meta分析结果显示:4种联合治疗方式与单纯口服普萘洛尔相比疗效均优于单纯口服普萘洛尔治疗。普萘洛尔联合注射平阳霉素、普萘洛尔联合外用噻吗洛尔、普萘洛尔联合敷贴器的有效率均优于对应的注射平阳霉素、外用噻吗洛尔及敷贴器。各治疗措施的有效性排序为:普萘洛尔联合敷贴器>普萘洛尔联合外用噻吗洛尔>普萘洛尔联合口服糖皮质激素>普萘洛尔联合注射平阳霉素>敷贴器照射>外用噻吗洛尔>口服普萘洛尔>注射平阳霉素。结论:对于婴幼儿血管瘤的治疗,普萘洛尔联合治疗措施疗效均优于单纯的口服普萘洛尔治疗,其中普萘洛尔联合敷贴器的疗效最佳。 相似文献
89.
我国属胃癌高发国家,且以进展期胃癌为主。以手术和化疗为主的多学科治疗无法有效改善晚期胃癌患者的预后。近年来,免疫检查点抑制剂类药物的疗效在诸多癌症中得到了证实,因此,该类药物在胃癌中的治疗效果也受到了广泛的关注。本文对近年来的相关研究成果进行综述,全面介绍了免疫检查点抑制剂类药物在胃癌治疗中的临床应用情况、联合用药情况以及不良反应。对于其他治疗均失败的晚期胃癌患者,PD-1抑制剂是一个可行的治疗选项,其代表药物派姆单抗是目前唯一被美国食品药品监督管理局批准应用于胃癌治疗的免疫抑制剂类药物,而我国国家食品药品监督管理总局尚未批准任何此类药物应用于胃癌的临床治疗。如何进一步提高治疗的客观缓解率,将会是后续临床和基础研究的一大焦点。 相似文献
90.
Mina Jane Zafar Thomas Kallemose Mostafa Benyahia Lars Bo Ebskov Jeannette
stergaard Penny 《Acta orthopaedica》2020,91(4):444
Background and purpose — Total ankle arthroplasties (TAAs) have larger revision rates than hip and knee implants. We examined the survival rates of our primary TAAs, and what different factors, including the cause of arthritis, affect the success and/or revision rate.Patients and methods — From 2004 to 2016, 322 primary Hintegra TAAs were implanted: the 2nd generation implant from 2004 until mid-2007 and the 3rd generation from late 2007 to 2016. A Cox proportional hazards model evaluated sex, age, primary diagnosis, and implant generation, pre- and postoperative angles and implant position as risk factors for revision.Results — 60 implants (19%) were revised, the majority (n = 34) due to loosening. The 5-year survival rate (95% CI) was 75% (69–82) and the 10-year survival rate was 68% (60–77). There was a reduced risk of revision, per degree of increased postoperative medial distal tibial angle at 0.84 (0.72–0.98) and preoperative talus angle at 0.95 (0.90–1.00), indicating that varus ankles may have a larger revision rate. Generation of implant, sex, primary diagnosis, and most pre- and postoperative radiological angles did not statistically affect revision risk.Interpretation — Our revision rates are slightly above registry rates and well above those of the developer. Most were revised due to loosening; no difference was demonstrated with the 2 generations of implant used. Learning curve and a low threshold for revision could explain the high revision rate.Arthritis in the ankle often develops earlier than in the hip or knee, and 70% have a traumatic etiology (Saltzman et al. 2005, Brown et al. 2006). Total ankle arthroplasty (TAA) can be indicated for severe arthritis in the ankle joint, but the anatomical preconditions, like a small surface area and high stress from compression and torque (Bouguecha et al. 2011, Kakkar and Siddique 2011), makes it less durable than hip and knee prosthetics. The Hintegra TAA, a 3-component mobile bearing, uncemented implant (Hintermann et al. 2004) is widely used and results from the development center demonstrate survival rates of 94% and 84% after 5 and 10 years’ follow-up (Barg et al. 2013). This is considerably more than the survival rates from national registries. Labek et al. (2011) demonstrated that development centers report only half of the revision rate that can be found in the few existing national registers. In a systematic review of primary Agility total ankle arthroplasty (DePuy Synthes Orthopedics, Warsaw, IN, USA), the author (Roukis 2012) found that the incidence of complications increased from 7% to 12%, in studies where the inventor was excluded. Similar results were found by Prissel and Roukis (2013), who found an increased incidence of complications from 6% to 13% in studies where the inventor or faculty consultants were excluded. These studies indicated the risk of selection (inventor) and publication (conflict of interest) bias.Planning and surgical technique, including significant experience, are mandatory for a successful outcome. The better result from development centers may reflect, besides the above-mentioned bias, that there is a long learning curve and that the indication for revision surgery varies.We examined the survival rates of primary Hintegra TAAs performed at Hvidovre Hospital, with revision rate as outcome. We report primary diagnosis for primary TAA and examine whether sex, generation of the implant, preoperative angles and implant position affect the revision rate. 相似文献